Publications

Research Methods, Clinical Development & Regulatory Guides

Practical explanations and case-based analysis for researchers working across laboratory methods, biostatistics, translational research, and clinical drug development. The main collection focuses on applying experimental evidence and quantitative methods to research and development decisions.

Articles distinguish reported study findings from interpretation, link to primary literature or regulatory sources where available, and discuss limitations that matter when applying evidence to research or development decisions.

Core research and drug-development guides

Practical resources on experimental methods, translational research, biostatistics, clinical development, precision medicine, and regulatory decision-making.

Epidemiology & Public Health • May 2026

Colonoscopy Screening: Interpreting the 13-Year NordICC Trial Results

An examination of invitation to colonoscopy in the NordICC trial, including the absolute difference in colorectal cancer diagnoses and the distinction between screening uptake, cancer incidence, and mortality outcomes.

menu_book Read Article
Clinical Trial Strategy • Jul 2026

Proof of Concept in First-in-Class Drugs: The Midostaurin Case

A case study of the early CPKC412A2104 core cohort, in which Novartis used a prespecified response threshold of at least 2 of 12 participants as a program-specific PoC decision rule. The article distinguishes that early decision from blast-response findings in the separate 95-patient Phase IIb extension and explains why 2/12 is not a universal PoC standard.

menu_book Read Article
Precision Medicine • Aug 2015

BRACAnalysis CDx and Olaparib: A Case Study in Companion Diagnostics

A historical case study of the original BRACAnalysis CDx approval with olaparib, including the defined intended use and why biomarker eligibility and predictive value must be interpreted in the context of current labeling and study design.

menu_book Read Article
Clinical Trial Design • Updated Nov 2026

Evaluating Contribution of Effect in Novel Cancer Drug Combinations

A practical review of factorial designs, external comparator evidence, endpoint selection, and the FDA's nonbinding 2025 draft guidance for demonstrating each component's contribution in novel oncology combinations.

menu_book Read Article
Pharmacology • Aug 2024

Navigating the ICH M12 Guidance on Drug-Drug Interaction Studies

A practical development-stage framework for enzyme- and transporter-mediated DDI assessment, including when in-vitro signals may justify modeling or clinical studies and where M12's scope does not extend.

menu_book Read Article

Broader scientific research reviews

Selected reviews of neuroscience and computational research. These articles provide wider scientific context and are separate from the site's primary laboratory and drug-development tools.

Computational Biology • Aug 2026

Repeated Tokens, Attention Sinks, and LLM Context Loss

A review of research linking repeated-token divergence to attention-sink circuitry, with a careful look at what the findings do—and do not—establish for biological applications.

menu_book Read Article
Behavioral Science • Jun 2006

Social Modulation of Pain in Mice: Evidence and Limits

A review of a 2006 Science study on social modulation of pain-related behavior in mice, distinguishing the observed behavioral findings from interpretations about subjective empathy.

menu_book Read Article